首页 › 基金 › Samsara BioCapital, LLC › VRDN
Samsara BioCapital, LLC 对 VRDN 的持仓历史
VIRIDIAN THERAPEUTICS INC · 医疗保健
Samsara BioCapital, LLC 在 Q3 2026 的 13F 申报中披露持有 VRDN(VIRIDIAN THERAPEUTICS INC)837,173 股,市值约 US$11.5M,约占其申报组合的 1.09%,在其申报持仓中市值排名第 13 位。 Samsara BioCapital, LLC 于 Q3 2026 首次申报该持仓。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
Samsara BioCapital, LLC 对 VRDN 的持仓演变
Samsara BioCapital, LLC 于 Q3 2026 首次披露 VRDN 持仓:837,173 股(约 US$11.5M)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2026 | 837.17K | $11.49M | 新进 |
关于 VRDN 与 13F 数据
VRDN(VIRIDIAN THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 41 只申报持有 VRDN,申报仓位最大的包括:Paradigm Biocapital Advisors LP (US$227.1M), Bellevue Group AG (US$146.4M), Kynam Capital Management, LP (US$126.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 VRDN 的基金
- Paradigm Biocapital Advisors LP 12.41M 股 · $227.08M · Q3 2026
- Bellevue Group AG 7.11M 股 · $146.38M · Q3 2026
- Kynam Capital Management, LP 6.15M 股 · $126.59M · Q3 2026
- Fairmount Funds Management LLC 5.09M 股 · $104.82M · Q3 2026
- RTW INVESTMENTS, LP 4.98M 股 · $102.03M · Q3 2026
- RA CAPITAL MANAGEMENT, L.P. 5.96M 股 · $81.79M · Q3 2026
- Novo Holdings A/S 4.87M 股 · $78.92M · Q3 2026
- Venrock Adviser, LLC 3.26M 股 · $67.08M · Q3 2026
- Deep Track Capital, LP 3.83M 股 · $64.34M · Q3 2026
- Atlas Venture Life Science Advisors, LLC 4.50M 股 · $61.83M · Q3 2026
- Caligan Partners LP 3.08M 股 · $57.34M · Q3 2026
- Context Capital Management, LLC 49.00M 股 · $56.47M · Q3 2026
更多关于 Samsara BioCapital, LLC
常见问题
How long has Samsara BioCapital, LLC held VRDN?
Samsara BioCapital, LLC has disclosed VRDN holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Samsara BioCapital, LLC's current position in VRDN?
As of Q3 2026, Samsara BioCapital, LLC holds 837.17K shares of VRDN (VIRIDIAN THERAPEUTICS INC), valued at $11.49M, representing 1.09% of its reported portfolio and ranking #13.
Has Samsara BioCapital, LLC been buying or selling VRDN?
In the latest 13F filing (Q3 2026), Samsara BioCapital, LLC newly opened its position in VRDN.
Which other funds hold VRDN?
Other major institutional holders of VRDN include Paradigm Biocapital Advisors LP, Bellevue Group AG, Kynam Capital Management, LP, among 41 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.